Anesthesia on Optic Nerve Sheath Diameter
The Effect Of Minimal and High Flow Anesthesia on Optic Nerve Sheath Diameter in Laparotomic Gynecological Surgery
1 other identifier
interventional
80
1 country
1
Brief Summary
Different amounts of anesthetic gas can be used in the obstetric gynecological surgery operations to be performed with open method. Researchers aimed to compare the effect of gas changes on intraocular nerve diameter by ultrasonography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2019
CompletedFirst Submitted
Initial submission to the registry
March 10, 2020
CompletedFirst Posted
Study publicly available on registry
May 29, 2020
CompletedMarch 3, 2026
March 1, 2026
6 months
March 10, 2020
March 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Optic Nerve Sheath Diamater
Optic nerve sheath diamater measurements of the patients were recorded before and during the surgery at specified time points (T0: awake, T1: High fresh gas flow after induction at the 10th min., T2: Inhalation anesthesia at the 30th min., T3: Inhalation anesthesia at the 60th min., T4: Inhalation anesthesia at the 90th min., T5: Before extubation).A typical optic nerve sheath is generally less than 5 mm in diameter, and diameters greater than 5.5 mm predict an ICP of ≥20 cm H2O with 100% sensitivity and specifity
2 hours operation time
Secondary Outcomes (2)
Peroperative Complications
2 hours operation time
Postoperative Complications
postop 20 minutes
Study Arms (2)
High Flow Anesthesia, Low Flow Anesthesia
PLACEBO COMPARATOR. The patients were randomly allocated to one of the two groups of fresh gas flows using the closed-envelope technique: 2 L/min high flow and 0.5 L/min minimal flow. Group 1 (n = 40) was operated under high flow anesthesia with 50% O2 - 50% air at 2 L/min and desflurane at 1.1 MAC for the duration of the surgery. For anesthesia maintenance, Group 2 (n=40) was administered 50% oxygen - 50% air at 2 L/min and desflurane for 10-15 minutes. After reaching 1.1 MAC, it was switched to minimal flow with 50-60% oxygen- 40-50% air at 0.5 L/min and desflurane. 10 minutes before the end of the surgery, it was switched to high flow with 50% oxygen -50% air at 2 L/min.
Peroperetive Optic Nerve Sheath Diameter
ACTIVE COMPARATOROptic nerve sheath diameter measurements were performed by an experienced and the same anesthetist. In the measurements, the GE Healthcare Logiq e series USG device and 12-MHz linear probe were used. Longitudinal and transverse axis images were obtained on both eyelids while the patient was in the supine position. Measurements were taken 3 mm behind the optic nerve head
Interventions
The patients were randomly allocated to one of the two groups of fresh gas flows using the closed-envelope technique: 2 L/min high flow and 0.5 L/min minimal flow.
Eligibility Criteria
You may qualify if:
- Aged 18-65 years
- ASA I-II
- Who underwent laparotomic gynecological surgery
You may not qualify if:
- Patients with obstructive pulmonary disease
- Patients with decompensated diabetes, those with a fasting period of more than 12 hours -Acute alcohol intoxication
- Chronic alcohol use
- Who refuse to participate in the study
- Who are not cooperative, do not speak Turkish
- Who had known eye disease (glaucoma, retinal detachment), had a previous history of eye surgery,
- Increased intracranial pressure findings (intracranial lesion, previous cerebrovascular diseases
- Body mass index of \> 40kg/m2
- ASA \> III
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital
Bursa, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Anıl Onur, MD
University of Health Science Bursa Yüksek Ihtisas Training and Research Hospital
- STUDY DIRECTOR
H.Erkan Sayan, MD
University of Health Science Bursa Yüksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Tugba Onur, MD
University of Health Science Bursa Yüksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Umran Karaca, MD
University of Health Science Bursa Yüksek Ihtisas Training and Research Hospital
- STUDY CHAIR
Canan Yılmaz, MD
University of Health Science Bursa Yüksek Ihtisas Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle İnvestigator
Study Record Dates
First Submitted
March 10, 2020
First Posted
May 29, 2020
Study Start
April 30, 2019
Primary Completion
October 30, 2019
Study Completion
December 30, 2019
Last Updated
March 3, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share